DocGo Q4 EPS $0.07 Misses $0.10 Estimate, Sales $199.25M Beat $194.21M Estimate
Portfolio Pulse from Benzinga Newsdesk
DocGo (NASDAQ:DCGO) reported Q4 earnings of $0.07 per share, missing the consensus estimate of $0.10, a 30% decrease from last year. However, their quarterly sales of $199.25M exceeded estimates by 2.59%, marking an 83.13% increase from the previous year.
February 28, 2024 | 9:50 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
DocGo reported lower-than-expected Q4 EPS at $0.07, missing estimates by 30%, but surpassed sales forecasts with $199.25M, a significant year-over-year increase.
The miss in EPS could negatively impact investor sentiment and stock price in the short term. However, the significant beat in sales and year-over-year growth might offset this negative impact, leading to a neutral short-term price direction. The mixed results present both positive and negative signals to investors, making the overall impact on the stock price uncertain.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100